ADHD management starts with a discussion

Answer a few questions and get your free personalized guide

Make the most of your next healthcare provider visit

If you think you or your child are experiencing symptoms of ADHD, or the current approach to ADHD management is not the right fit, speaking to your or your child’s healthcare provider can help get a diagnosis and a treatment plan.

Appointments are an opportunity to connect on a treatment plan and overall ADHD management, but often can be over before you realize it and it’s easy to forget things you wanted to discuss.

Get a free customized Discussion Guide

Identify core topics for discussion

Remember symptoms

Have real-life examples at the ready

Answer a few questions and your free personalized guide will be ready to download

Get a Discussion Guide for yourself

If you are an adult living with or experiencing symptoms of ADHD

Get your guide

Get a Discussion Guide for your child

If your child 6-17 years old has ADHD or you think they are experiencing symptoms of ADHD

Get a guide for your child

If I had any advice, I would say that it’s okay to reach out and see if there is anything that can be done."

Megan

Adult with ADHD
Paid spokesperson for Qelbree

See Megan’s story

You don’t have to be sure to ask about ADHD

Managing ADHD is a journey, from being diagnosed to managing symptoms in ways that work best for you or your child. Learn more about what to look for if you think ADHD may be affecting you or your child. Only a healthcare provider can diagnose ADHD.

Learn more about ADHD

See how Qelbree may help

INDICATION

Qelbree^® (viloxazine extended-release capsules) is a prescription medicine used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults and children 6 years and older.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment [read more] or when the dose is changed. Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment or when the dose is changed. [read more] Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

You should not take Qelbree if you or your child:
Take a medicine for depression called a monoamine oxidase inhibitor (MAOI) or have stopped taking an MAOI in the past 14 days. Also, you or your child should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.

Qelbree can increase blood pressure and heart rate. Your or your child’s doctor will monitor these vital signs.

Qelbree may cause manic episodes in patients with bipolar disorder. Tell your doctor if you or your child show any signs of mania.

Do not drive or operate heavy machinery until you know how Qelbree will affect you or your child. Qelbree may cause you or your child to feel sleepy or tired.

The most common side effects of Qelbree in patients 6 to 17 years are sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability, and in adults, insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation. These are not all the possible side effects of Qelbree.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Medication Guide, including Boxed Warning.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE